Sirtris Pharmaceuticals, Inc.
Cambridge, MA 02139 (Map) Phone: 617-252-6920
Fax: 617-252-6924
http://www.sirtrispharma.com
Overview
Sirtris can help keep you healthy in your golden years. The biopharmaceutical company focuses on developing drugs for treating ailments of aging. Its primary candidate is designed to treat Type 2 Diabetes, which is associated with obesity, by providing health benefits similar to calorie restriction without a change in diet. Other candidates include drugs to treat cancer, cardiovascular, and other diseases often linked to obesity. Sirtris owns or licenses several patent applications for sirtuins, a class of enzymes believed to be associated with the aging process. The activation of sirtuins helps reduce weight gain and improve glucose levels and insulin sensitivity. Sirtris is a subsidiary of GlaxoSmithKline.
Sample OverviewKey Numbers from Hoover's UK
Key financials for Sirtris Pharmaceuticals, Inc.
| Company Type | Subsidiary of GlaxoSmithKline |
|---|---|
| Fiscal Year-End | December |
Key People from Hoover's UK
Key people and executives for Sirtris Pharmaceuticals, Inc.
| CEO | Christoph H. Westphal (Subscribers see complete biographies -- view sample)
|
|---|---|
| COO | Garen G. Bohlin |
| VP Finance | Paul Brannelly |
Top Competitors from Hoover's UK
Top competitors of Sirtris Pharmaceuticals, Inc.
There are 17 competitors for Sirtris; see more.
